Charles E. Geyer, MD and Ian E. Krop, MD, PhD review current trends in the breast cancer treatment landscape, discuss new data presented at the 2022 San Antonio Breast Cancer Symposium as well as other major findings presented over the course of the year.
EP. 1: The Evolution of the Breast Cancer Treatment LandscapeJanuary 11th 2023
Charles E. Geyer, MD and Ian E. Krop, MD, PhD provide an overview of the current breast cancer treatment landscape, with a focus on the management of patients with ER+/HER2- metastatic breast cancer.
EP. 5: Recent Updates for the Advanced HR+ Breast Cancer SettingJanuary 25th 2023
Charles E. Geyer, MD and Ian E. Krop, MD, PhD touch on recent advances in the metastatic HR+ breast cancer setting and evaluate PROTAC estrogen receptor (ER) degraders compared with other ER modulators.
EP. 6: Key Takeaways from Clinical Trials of Trastuzumab Deruxtecan in Different PopulationsJanuary 25th 2023
Dr Krop leads a discussion of results from the DESTINY-Breast02 and DESTINY-Breast03 studies concerning the use of trastuzumab deruxtecan in patients with metastatic breast cancer.
EP. 7: Unmet Needs for Patients with HER2+ Breast Cancer with Brain MetastasesFebruary 1st 2023
Breast cancer experts exchange thoughts on the treatment of HER2+ breast cancer with CNS involvement, particularly the use of trastuzumab deruxtecan in this subset of patients.